Emcure Pharmaceuticals has released its audited financial results for the quarter and year ended 31 March 2026. The announcement was made following a board meeting held on 5 May 2026, where the results were reviewed and recommended by the Audit Committee.
The company provided both standalone and consolidated financial results, which were audited by M/s. B S R & Co. LLP, Chartered Accountants, the statutory auditors of Emcure Pharmaceuticals. The audited financial results are enclosed in Annexure A of the regulatory filing.
In addition to the financial results, Emcure Pharmaceuticals has issued a press release outlining key updates on its performance for the quarter and year ended 31 March 2026. This press release is included in Annexure B of the filing.
The financial results and the accompanying audit reports are in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).